Scienceblogtwo

The virus that causes COVID-19, SARS-CoV-2, can be precisely located using a new designed CRISPR-based technique. The extremely sensitive detector promises to make COVID-19 and other illness testing quick and simple. Researchers from Rice University and the University of Connecticut improved the CRISPR-Cas13 RNA-editing technology to increase its capability of spotting minute quantities of the SARS-CoV-2 virus in biological samples. It does this without the time-consuming RNA extraction and amplification phase required in gold-standard PCR testing, which is a major advantage. Comparing the novel platform to PCR testing, it was quite successful. In reality, tests on clinical samples obtained directly from nose swabs revealed 10 out of 11 positives and no false positives for the virus. The researchers demonstrated how their method can detect SARS-CoV-2 in quantities as low as attomolar (10–18). The research will be released in the journal Nature Chemical Biology today, September 22, 2022...

During the "Amerithrax" assaults of 2001, anthrax-causing spores were sent to news organizations and members of Congress, infecting at least 22 individuals and killing 5. Antibiotic-resistant strains of the bacteria are a growing cause of concern, therefore researchers are preparing to battle them. Now, according to a paper published in the journal ACS Infectious Diseases today (September 14, 2022), a team has made headway toward the development of a medication that might treat the infection in mice without the use of antibiotics. A gram-positive, rod-shaped bacteria called Bacillus anthracis can cause anthrax infection when its spores are consumed, inhaled, or come into contact with a skin wound. Infection with anthrax can cause breathing problems, skin sores, or even death. Although there are medications that can combat anthrax, over time drug resistance can develop. The B. anthracis bacteria's capsule can be broken apart by a designed enzyme with fragments of antibody ...

A group of Mount Sinai researchers have created a high-resolution crystal structure of an enzyme required for SARS-CoV-2, the virus that causes COVID-19, to survive. The discovery may aid in the development of critically needed new antivirals to fight coronaviruses both now and in the future. The RNA methyltransferase domain, a crucial component of the enzyme known as nsp14, is present. The three-dimensional crystal structure of this region has defied prior attempts by the scientific community to characterize it. The novel procedure is described in a publication that was released in Nature Structural & Molecular Biology's online edition on September 8. Aneel Aggarwal, PhD, a senior author on the paper, notes that being able to see the methyltransferase domain of nsp14 in high resolution provides insights into how to build tiny compounds that fit into its active site and thereby hinder its crucial chemistry. At Mount Sinai's Icahn School of Medicine, he has the title of Prof...

It's ironic that certain immunizations require additional "boosters." Adjuvants, which help vaccines elicit a more powerful immune response and better prepare the body to combat pathogens, can be added to vaccines. According to research, an additive increased the immune response to an experimental COVID-19 injection in mice by 25 times more than the vaccination alone. A new publication detailing the discovery was released in the ACS Infectious Diseases journal today, August 31, 2022. Some vaccinations contain an adjuvant, which aids in the development of a stronger immune response in recipients. In other words, adjuvants increase the effectiveness of immunizations. Despite the use of cutting-edge mRNA genetic technology in the first COVID-19 injections approved in the U.S., the tried-and-true method of employing pathogen proteins can result in vaccinations that are less expensive to develop and simpler to store. Only one protein-based vaccination against SARS-CoV-2 has be...

The first incidence of polio in the United States since 2013 was reported by New York state health officials on July 21, 2022. The American resident, who has paralysis and weakened muscles, was not immunized. Prior to the development of secure and reliable vaccinations in the middle of the 20th century, polio was a frequent cause of childhood paralysis. Polio has nearly been eliminated as a result of international immunization initiatives. Only 13 endemic wild poliovirus infections have been recorded globally so far in 2022. According to reports, a kind of polio that the New York patient developed can be linked to the live but weakened poliovirus used in the oral polio vaccination. Since 2000, the United States has not employed this particular vaccination. Health experts said the virus that was infecting the male patient most likely came from a country where oral vaccinations are still used. Specialist in infectious diseases and head of the Polio Research Committee for the World Health...